Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Shenfu injection for sepsis-induced myocardial dysfunction
ChiCTR2000039035Phase 4Recruiting
- Sponsor
- Jiangsu Province Hospital on Integration of Chinese and Western Medicine
- Start
- Oct 2020
- Countries
- 1
01
Overview
Phase 4 trial of shenfu injection in myocardial dysfunction and septic shock (2 arms), sponsored by Jiangsu Province Hospital on Integration of Chinese and Western Medicine. Primary endpoints: Left ventricular size, Left ventricular ejection fraction (LVEF) and 2 more. Started Oct 2020; status: recruiting.
02
Drugs
shenfu injection
03
Conditions
myocardial dysfunctionseptic shock
Beyond the preview
Go deeper on ChiCTR2000039035.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000039035.